FHTX R&D Expenses
Foghorn Therapeutics Inc · R&D Expenses
FHTX R&D Expenses
Latest reported$79.73Mperiod ending
FHTX R&D Expenses ($21.23M → $79.73M)
Annual R&D Expenses
High-resolution chart · PNG
FHTX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 85,466,000 | |
| 94,528,000 | |
| 109,689,000 | |
| 105,618,000 | |
| 80,325,000 | |
| 57,715,000 | |
| 44,362,000 | |
| 21,225,000 |